192 related articles for article (PubMed ID: 24463278)
21. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
22. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.
Adamaki M; Lambrou GI; Athanasiadou A; Tzanoudaki M; Vlahopoulos S; Moschovi M
PLoS One; 2013; 8(8):e72326. PubMed ID: 23977280
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.
Chen YY; Li ZZ; Ye YY; Xu F; Niu RJ; Zhang HC; Zhang YJ; Liu YB; Han BS
BMC Mol Biol; 2016 Mar; 17():6. PubMed ID: 26935744
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
[TBL] [Abstract][Full Text] [Related]
26. SALL4 is a new target in endometrial cancer.
Li A; Jiao Y; Yong KJ; Wang F; Gao C; Yan B; Srivastava S; Lim GS; Tang P; Yang H; Tenen DG; Chai L
Oncogene; 2015 Jan; 34(1):63-72. PubMed ID: 24336327
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
28. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
29. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
[TBL] [Abstract][Full Text] [Related]
30. Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21.
Itou J; Li W; Ito S; Tanaka S; Matsumoto Y; Sato F; Toi M
J Biol Chem; 2018 Apr; 293(17):6556-6564. PubMed ID: 29511085
[TBL] [Abstract][Full Text] [Related]
31. Aberrant hypomethylation of SALL4 gene is associated with intermediate and poor karyotypes in acute myeloid leukemia.
Ma JC; Qian J; Lin J; Qian W; Yang J; Wang CZ; Chai HY; Li Y; Chen Q; Qian Z
Clin Biochem; 2013 Mar; 46(4-5):304-7. PubMed ID: 23201546
[TBL] [Abstract][Full Text] [Related]
32. Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22).
Takahashi T; Mizutani M; Miwa H; Katayama N; Nishii K; Shikami M; Yamaguchi M; Shiku H; Kamada N; Kita K
Int J Hematol; 1998 Jun; 67(4):369-78. PubMed ID: 9695410
[TBL] [Abstract][Full Text] [Related]
33. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.
He J; Zhang W; Zhou Q; Zhao T; Song Y; Chai L; Li Y
Int J Biochem Cell Biol; 2013 Sep; 45(9):1962-73. PubMed ID: 23811124
[TBL] [Abstract][Full Text] [Related]
34. Stem cell gene SALL4 suppresses transcription through recruitment of DNA methyltransferases.
Yang J; Corsello TR; Ma Y
J Biol Chem; 2012 Jan; 287(3):1996-2005. PubMed ID: 22128185
[TBL] [Abstract][Full Text] [Related]
35. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
37. Targeting SALL4 by entinostat in lung cancer.
Yong KJ; Li A; Ou WB; Hong CK; Zhao W; Wang F; Tatetsu H; Yan B; Qi L; Fletcher JA; Yang H; Soo R; Tenen DG; Chai L
Oncotarget; 2016 Nov; 7(46):75425-75440. PubMed ID: 27705911
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21.
Willis TG; Zalcberg IR; Coignet LJ; Wlodarska I; Stul M; Jadayel DM; Bastard C; Treleaven JG; Catovsky D; Silva ML; Dyer MJ
Blood; 1998 Mar; 91(6):1873-81. PubMed ID: 9490669
[TBL] [Abstract][Full Text] [Related]
39. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.
Kordes U; Krappmann D; Heissmeyer V; Ludwig WD; Scheidereit C
Leukemia; 2000 Mar; 14(3):399-402. PubMed ID: 10720133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]